Abstract
Renal disease is an ongoing and growing problem around the world and in Turkey. Almost %5 of health expenditures are about kidney patients in Turkey. The amount of patients is increasing every day although the donation rates are not increasing in the same speed. The governments are applying different regimes for closing the gap between supply and demand on kidney. These systems are not accurate to close this gap. Main classification of these techniques is opt - in and opt - out regimes. The cost of dialysis for every patient is higher than the cost of transplantation. The transplanted patient lives 22 years whether dialysis patient lives 14 years. Transplantation is cost –effective than dialysis. It is an obligation to decrease the number of patients in the waiting list. In 2014 there are almost 60.000 kidney disease patients in Turkey and 29.000 of them are ESRD patients. Almost 4200 of them are transplanted in 2014. One of the solutions of closing this difference is to pay monetary incentive to possible living donors. Among the ethical debates on monetarizing the human body, this article is focused on the quantity of monetary incentive that would pay to the possible donors. This amount is the collection of the costs of statistical value of life, death-risk component, quality of life component and value of time. It is the quantity of losses, not the value of a kidney. The quantity differs according to the value of statistical life. Average price for these losses are 8.638 TL.
Highlights
Renal impairment is a disease which is rapidly approaching to be a problem in Turkey and in the world
When it is considered that the costs of dialysis – even if the highest Statistical Value of Life (SVL) is taken for calculation – are more expensive than total kidney value, it can be said that giving monetary incentive payment will result in decreasing/ending kidney waiting-list patients and gainin economy will be higher
The calculations done in this article are not related with commodification of human body
Summary
Renal impairment is a disease which is rapidly approaching to be a problem in Turkey and in the world. Applying monetary incentive fororgan donation (it can be named as selling kidney) is a subject that has different aspects. Direct incentive is based on making payment in cash to donor or donor’s family In this type of system, different alternatives are proposed about the quantity and the way of the payment. The subjects handled at some of the surveys focused on the question: “if there is financial incentive, will you donate?” rather than the quantity (Mohamed & Guella: 2013; Mayrhofer – Reinhartshuber: 2006). Another debate is from whom the organ will be taken. According to researchers’ results, this type of incentive results in a comparable growth at donor numbers (Jasper et al.:1999; DeJong et al.:1995)
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
